West Pharmaceutical Services, Inc. (BVMF:W2ST34)
Brazil
· Delayed Price · Currency is BRL 40.76
-2.44 (-5.65%)
At close: Nov 7, 2025
BVMF:W2ST34 Revenue
West Pharmaceutical Services had revenue of $804.60M USD in the quarter ending September 30, 2025, with 7.73% growth. This brings the company's revenue in the last twelve months to $3.02B, up 4.92% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$3.02B
Revenue Growth
+4.92%
P/S Ratio
6.78
Revenue / Employee
$284.71K
Employees
10,600
Market Cap
109.12B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |